Tuberculosis
Overview
The U.S. Agency for International Development (USAID), in close collaboration with global, regional, and developing country partners, is committed to addressing the global burden of tuberculosis (TB), which kills about 1.7 million people annually. Over the past six years the United States has helped provide effective treatment for 10 million people with TB in 78 countries. The U.S. Government, through USAID, is the leading bilateral donor in the world for TB and supports the expansion and strengthening of TB control in 40 countries. Between 2000 and 2008, USAID provided about $777 million to support TB programs worldwide.
USAID's goal is to make a significant contribution to global, regional, and national efforts to prevent and control tuberculosis and reduce morbidity and mortality associated with the disease. The Agency’s support strengthens the ability of countries most affected by TB to expand the use of proven and cost-effective interventions – such as the internationally recognized Directly-Observed Therapy, Short Course (DOTS) strategy – and achieve the World Health Organization (WHO) targets for TB case detection and cure rates. USAID is also addressing theemerging threat of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB by stepping up support to strengthen laboratories to improve case detection, infection control, surveillance, and training of health care providers in the diagnosis and treatment of MDR and XDR TB, all key components of the Global Response Plan.
USAID's Program Description
for Combating Tuberculosis
USAID's Expanded
Response to Tuberculosis [PDF, 135KB] focuses on
five key areas:
- DOTS Expansion and Enhancement
- Scale up Management of MDR-TB and XDR-TB
- Address TB HIV co-infection
- Strengthen health systems and human resource capacity
- Develop new tools and improved approaches
|